Chronic rejection of human kidney allografts

References

• Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996.N. Engl. J. Med.342(9), 605–612 (2000).
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Gaston RS, Gourishankar S et al. Long-term deterioration of kidney allograft function.Am. J. Transplant.5(6), 1405–1414 (2005).
   PubMed Web of Science ®Google Scholar
• Joosten SA Sijpkens YW, van Kooten C, Paul LC. Chronic renal allograft rejection: pathophysiologic considerations.Kidney Int.68(1), 1–13 (2005).
   PubMed Web of Science ®Google Scholar
• Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy.N. Engl. J. Med.349(24), 2326–2333 (2003).
   PubMedGoogle Scholar
• Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology.Kidney Int.55(2), 713–723 (1999).
   PubMed Web of Science ®Google Scholar
• Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.Kidney Int.44(2), 411–422 (1993).
   PubMed Web of Science ®Google Scholar
• Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors.Kidney Int.49(2), 518–524 (1996).
   PubMed Web of Science ®Google Scholar
• Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.J. Am. Soc. Nephrol.13(9), 2371–2380 (2002).
   PubMed Web of Science ®Google Scholar
• Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.J. Am. Soc. Nephrol.12(3), 574–582 (2001).
   PubMed Web of Science ®Google Scholar
• Oikawa T, Morozumi K, Koyama K et al. Electron microscopic peritubular capillary lesions: a new criterion for chronic rejection.Clin Transplant13(Suppl. 1), 24–32 (1999).
   Google Scholar
• Krieger NR, Becker BN, Heisey DM et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts.Transplantation75(10), 1677–1682 (2003).
   PubMed Web of Science ®Google Scholar
• Benichou G. Direct and indirect antigen recognition: the pathways to allograft immune rejection.Front. Biosci.4, D476–D480 (1999).
   PubMedGoogle Scholar
• Roussey-Kesler G, Brouard S, Ballet C et al. Exhaustive depletion of graft resident dendritic cells: marginally delayed rejection but strong alteration of graft infiltration.Transplantation80(4), 506–513 (2005).
   PubMedGoogle Scholar
• Liu Z, Sun YK, Xi YP et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity.J. Exp. Med.177(6), 1643–1650 (1993).
   PubMed Web of Science ®Google Scholar
• Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy.J. Immunol.167(12), 7199–7206 (2001).
   PubMedGoogle Scholar
• Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.J. Am. Soc. Nephrol.13(1), 252–259 (2002).
   PubMed Web of Science ®Google Scholar
• Ciubotariu R, Liu Z, Colovai AI et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.J. Clin. Invest.101(2), 398–405 (1998).
   PubMed Web of Science ®Google Scholar
• Vella JP, Spadafora-Ferreira M, Murphy B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.Transplantation64(6), 795–800 (1997).
   PubMed Web of Science ®Google Scholar
• Jiang S, Herrera O, Lechler RI. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.Curr. Opin. Immunol.16(5), 550–557 (2004).
   PubMed Web of Science ®Google Scholar
• Sherman LA, Chattopadhyay S. The molecular basis of allorecognition.Annu. Rev. Immunol.11, 385–402 (1993).
   PubMed Web of Science ®Google Scholar
• Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.J. Immunol.166(2), 973–981 (2001).
   PubMed Web of Science ®Google Scholar
• Bendjelloul F, Desin TS, Shoker AS. Donor non-specific IFN-γ production by primed alloreactive cells as a potential screening test to predict the alloimmune response.Transpl. Immunol.12(2), 167–176 (2004).
   PubMed Web of Science ®Google Scholar
• Baeten D, Louis S, Braud C et al. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.J. Am. Soc. Nephrol.17(1), 294–304 (2005).
   PubMed Web of Science ®Google Scholar
• Poggio ED, Clemente M, Riley J et al. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy.J. Am. Soc. Nephrol.15(7), 1952–1960 (2004).
   PubMedGoogle Scholar
• Bonneville M, Moreau JF, Blokland E et al. T lymphocyte cloning from rejected human kidney allograft. Recognition repertoire of alloreactive T cell clones.J. Immunol.141(12), 4187–4195 (1988).
   PubMedGoogle Scholar
• Kreisel D, Krupnick AS, Gelman AE et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition.Nature Med.8(3), 233–239 (2002).
   PubMed Web of Science ®Google Scholar
• Humar A, Kerr S, Gillingham KJ, Matas AJ. Features of acute rejection that increase risk for chronic rejection.Transplantation68(8), 1200–1203 (1999).
   PubMed Web of Science ®Google Scholar
• Soulillou JP, Peyrat MA, Guenel J. Association between treatment-resistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens.Lancet1(8060), 354–356 (1978).
   PubMedGoogle Scholar
• Gagne K, Brouard S, Giral M et al. Highly altered V β repertoire of T cells infiltrating long-term rejected kidney allografts.J. Immunol.164(3), 1553–1563 (2000).
   PubMed Web of Science ®Google Scholar
• Illigens BM, Yamada A, Fedoseyeva EV et al. The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant.Hum. Immunol.63(10), 912–925 (2002).
   PubMed Web of Science ®Google Scholar
• Opelz G. New immunosuppressants and HLA matching.Transplant Proc.33(1–2), 467–468 (2001).
   PubMedGoogle Scholar
• Pawlik A, Domanski L, Rozanski J et al. The cytokine gene polymorphisms in patients with chronic kidney graft rejection.Transpl. Immunol.14(1), 49–52 (2005).
   PubMedGoogle Scholar
• Sakaguchi S, Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.Nat. Immunol.6(4), 345–352 (2005).
   PubMed Web of Science ®Google Scholar
• von Boehmer H, Mechanisms of suppression by suppressor T cells.Nature Immunol.6(4), 338–344 (2005).
   PubMed Web of Science ®Google Scholar
• Hsieh CS, Rudensky AY. The role of TCR specificity in naturally arising CD25+ CD4+ regulatory T cell biology.Curr. Top. Microbiol. Immunol.293, 25–42 (2005).
   PubMedGoogle Scholar
• Taams L, Vukmanovic-Stejic M, Salmon M, Akbar A. Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance.Transpl. Immunol.11(3–4), 277–285 (2003).
   PubMedGoogle Scholar
• Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH. Regulatory CD25+ T cells in human kidney transplant recipients.J. Am. Soc. Nephrol.14(6), 1643–1651 (2003).
   PubMedGoogle Scholar
• Louis S, Braudeau C, Giral M et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.Transplantation81(3), 398–407 (2006).
   PubMed Web of Science ®Google Scholar
• Muthukumar T, Dadhania D, Ding R et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients.N. Engl. J. Med.353(22), 2342–2351 (2005).
   PubMed Web of Science ®Google Scholar
• Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial.Transplantation80(9), 1194–1197 (2005).
   PubMed Web of Science ®Google Scholar
• Susal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens.Transplantation73(8), 1269–1273 (2002).
   PubMedGoogle Scholar
• El Fettouh HA, Cook DJ, Bishay E et al. Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation.Urology56(3), 369–372 (2000).
   PubMedGoogle Scholar
• Terasaki PI. Humoral theory of transplantation.Am. J. Transplant.3(6), 665–673 (2003).
   PubMed Web of Science ®Google Scholar
• Mizutani K, Terasaki P, Rosen A et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure.Am. J. Transplant.5(9), 2265–2272 (2005).
   PubMed Web of Science ®Google Scholar
• Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.Transplantation75(7), 1034–1040 (2003).
   PubMed Web of Science ®Google Scholar
• Hourmant M, Cesbron-Gautier A, Terasaki PI et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.J. Am. Soc. Nephrol.16(9), 2804–2812 (2005).
   PubMed Web of Science ®Google Scholar
• Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies.Transplantation74(8), 1192–1194 (2002).
   PubMed Web of Science ®Google Scholar
• Soulillou JP, de Mouzon-Cambon A, Dubois C, Blanc M, Peyrat MA, Mahieu P. Immunological studies of eluates of 83 rejected kidneys: screening of antibodies directed against T and B lymphocytes, glomerular and tubular basement membranes, DNA, and IgG.Transplantation32(5), 368–374 (1981).
   PubMedGoogle Scholar
• Sijpkens YW, Joosten SA, Wong MC et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy.Kidney Int.65(6), 2409–2418 (2004).
   PubMedGoogle Scholar
• Le Bas-Bernardet S, Coupel S, Chauveau A, Soulillou JP, Charreau B. Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies.Transplantation78(12), 1729–1739 (2004).
   PubMedGoogle Scholar
• Feucht HE. Complement C4d in graft capillaries – the missing link in the recognition of humoral alloreactivity.Am. J. Transplant.3(6), 646–652 (2003).
   PubMed Web of Science ®Google Scholar
• Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection.Nature Rev. Immunol.5(10), 807–817 (2005).
   PubMed Web of Science ®Google Scholar
• Salama AD, Delikouras A, Pusey CD et al. Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody.Am. J. Transplant.1(3), 260–269 (2001).
   PubMedGoogle Scholar
• Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications.J. Am. Soc. Nephrol.13(1), 242–251 (2002).
   PubMed Web of Science ®Google Scholar
• Jin YP, Jindra PT, Gong KW, Lepin EJ, Reed EF. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection.Transplantation79(Suppl. 3), S19–S21 (2005).
   PubMed Web of Science ®Google Scholar
• Reed E, Ho E, Cohen DJ et al. Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients.Immunol. Res.12(1), 1–11 (1993).
   PubMedGoogle Scholar
• Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.Lancet365(9470), 1570–1576 (2005).
   PubMed Web of Science ®Google Scholar
• Sumitran-Holgersson S, Wilczek HE, Holgersson J, Soderstrom K. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts.Transplantation74(2), 268–277 (2002).
   PubMed Web of Science ®Google Scholar
• Le Bas-Bernardet S, Hourmant M, Coupel S, Bignon JD, Soulillou JP, Charreau B. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis.Am. J. Transplant.3(2), 167–177 (2003).
   PubMedGoogle Scholar
• Rolls HK, Kishimoto K, Dong VM et al. T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection.Transplantation74(7), 1053–1057 (2002).
   PubMedGoogle Scholar
• Joosten SA, Sijpkens YW, van Ham V et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy.Am. J. Transplant.5(2), 383–393 (2005).
   PubMedGoogle Scholar
• Barber LD, Whitelegg A, Madrigal JA, Banner NR, Rose ML. Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients.Transplantation77(10), 1604–1609 (2004).
   PubMedGoogle Scholar
• Carter V, Shenton BK, Jaques B et al. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.Transplant Proc.37(2), 654–657 (2005).
   PubMedGoogle Scholar
• Lu CY. Ischemia, injury, and renal allograft rejection.Curr. Opin. Nephrol. Hypertens.5(2), 107–110 (1996).
   PubMedGoogle Scholar
• Hidalgo LG, Halloran PF. Role of IFN-γ in allograft rejection.Crit. Rev. Immunol.22(4), 317–349 (2002).
   PubMed Web of Science ®Google Scholar
• Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney.Transplantation64(2), 190–197 (1997).
   PubMed Web of Science ®Google Scholar
• Shihab FS, Yamamoto T, Nast CC et al. Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts.J. Am. Soc. Nephrol.6(2), 286–294 (1995).
   PubMedGoogle Scholar
• Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.J. Am. Soc. Nephrol.15(1), 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis.Am. J. Transplant.5(6), 1367–1374 (2005).
   PubMed Web of Science ®Google Scholar
• Robertson, H, Ali S, McDonnell BJ, Burt AD, Kirby JA. Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition.J. Am. Soc. Nephrol.15(2), 390–397 (2004).
   PubMed Web of Science ®Google Scholar
• Donauer J, Rumberger B, Klein M et al. Expression profiling on chronically rejected transplant kidneys.Transplantation76(3), 539–547 (2003).
   PubMed Web of Science ®Google Scholar
• Flechner SM, Kurian SM, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.Am. J. Transplant.4(11), 1776–1785 (2004).
   PubMed Web of Science ®Google Scholar
• Scherer A, Krause A, Walker JR, Korn A, Niese D, Raulf F. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies.Transplantation75(8), 1323–1330 (2003).
   PubMedGoogle Scholar
• Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.Lancet351(9103), 623–628 (1998).
   PubMed Web of Science ®Google Scholar
• Weir MR, Ward MT, Blahut SA et al. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.Kidney Int.59(4), 1567–1573 (2001).
   PubMed Web of Science ®Google Scholar
• Gjertson DW, Cecka JM, Terasaki PI. The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.Transplantation60(12), 1384–1388 (1995).
   PubMedGoogle Scholar
• Opelz G. Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study.Transpl. Int.5(Suppl. 1),S621–S624 (1992).
   Google Scholar
• Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes.Am. J. Transplant.4(9), 1475–1489 (2004).
   PubMed Web of Science ®Google Scholar
• Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial.Am. J. Transplant.4(3), 438–443 (2004).
   PubMed Web of Science ®Google Scholar
• Vincenti F, Larsen C, Durrbach A et al. Costimulation blockade with belatacept in renal transplantation.N. Engl. J. Med.353(8), 770–781 (2005).
   PubMed Web of Science ®Google Scholar
• Flechner SM, Modlin CS, Serrano DP et al. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.Transplantation62(9), 1235–1241 (1996).
   PubMed Web of Science ®Google Scholar
• Giral M, Nguyen JM, Daguin P et al. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction.J. Am. Soc. Nephrol.12(8), 1758–1763 (2001).
   PubMed Web of Science ®Google Scholar
• Trivedi HL, Shah VR, Vanikar AV et al. High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients.Pediatr. Transplant6(1), 63–68 (2002).
   PubMedGoogle Scholar
• Knechtle SJ, Hamawy MM, Hu H, Fechner JH Jr, Cho CS. Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation.Immunol. Rev.183, 205–213 (2001).
   PubMedGoogle Scholar
• Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection.Transplantation66(12), 1697–1701 (1998).
   PubMed Web of Science ®Google Scholar
• Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants.Clin. Transplant11(5 Pt 1), 366–372 (1997).
   PubMed Web of Science ®Google Scholar
• Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study.Kidney Int.53(1), 217–222 (1998).
   PubMedGoogle Scholar